Founded in 2014, Greenviki (Beijing) Biotechnology Co., Ltd. is an innovative biotechnology enterprise specializing in the R&D, production, and sales of high-quality Antarctic krill oil and its derivative products (nutritional foods and cosmetics). In addition, the company has expanded its footprint into ecological agriculture (humic acid raw materials) and international trade (plant extracts, APIs, and peptides), dedicating itself to providing premium health and beauty solutions to customers worldwide.

Core Business Sectors

Antarctic Krill Oil Series: Covering Antarctic krill oil raw materials, nutritional foods (softgels, gel candies, etc.), and high-end cosmetic products (masks, creams, lotions, etc.).

Ecological Agricultural Materials: In partnership with Aurun Bio since 2017, the company develops and manufactures high-quality sodium humate, potassium humate, and sodium fulvate.

Global Ingredient Trade: Supported by a dedicated international trade department established in 2017, Greenviki collaborates with China’s top 10 industry leaders to export premium plant extracts, Active Pharmaceutical Ingredients (APIs), and peptide products.

Elite R&D and Scientific Excellence

Greenviki considers technological innovation as its core driving force, backed by a profound scientific foundation:

Elite Talent Pool: The company boasts a dedicated R&D engineering team consisting of more than 10 Ph.D. and Master’s degree holders.

National-Level Track Record: The R&D team has led or participated in the National 863 Program and multiple provincial and ministerial science and technology projects. Crucially, the team participated in the application and registration of China’s very first Antarctic krill oil as a New Food Raw Material.

Synergistic Partnerships: Greenviki has established long-term project collaborations and academic partnerships with prestigious domestic and international research institutes, including the Dalian Institute of Chemical Physics (Chinese Academy of Sciences) and the Dalian University of Technology.

Robust Production & Manufacturing Capacity

Greenviki operates industry-leading manufacturing bases, achieving high-standard, large-scale automated production:

Raw Material Production: The company has built the largest krill oil production line in China, boasting an annual capacity of 400 tons.

Formulation Processing: It features fully automated production lines capable of manufacturing 100 million krill oil gel candies and softgels annually.

Corporate Vision

Guided by a rigorous scientific approach and backed by formidable R&D and manufacturing capabilities, Greenviki (Beijing) Biotechnology Co., Ltd. continues to deeply cultivate the bio-health sector, striving to become a trusted, industry-leading global biotechnology enterprise.